Oncology & Cancer

Experimental drug beneficial in NIH trial to treat a rare sarcoma

(Medical Xpress)—Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. The results from this largest clinical ...

Surgery

Breast CA tx delays still more common for poor, uninsured

(HealthDay)—For young women with breast cancer, a longer treatment delay time (TDT) is associated with decreased survival, especially for African-American women, those with public or no insurance, and those with low socioeconomic ...

Oncology & Cancer

Researchers discover breakthrough in ovarian cancer

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...

Surgery

One hospital night OK for robotic partial nephrectomy

(HealthDay)—Regardless of surgical complexity, most patients undergoing robotic partial nephrectomy (RPN) can be discharged in one day, according to a study published in the February issue of Urology.

Medications

Researchers find model system to study promising cancer drug

Researchers have found that the budding yeast (Saccharomyces cerevisiae) is an acceptable model system to study KP1019, an anti-cancer drug that uses ruthenium, a rare metal, a new study found. Researchers had previously ...

Oncology & Cancer

Tissue platinum concentrations linked to response in NSCLC

(HealthDay) -- For patients with non-small-cell lung cancer (NSCLC) who undergo neoadjuvant platinum-based chemotherapy, tissue platinum concentrations correlate positively with improved outcome, according to a study published ...

page 6 from 9